Attached files
| file | filename |
|---|---|
| EX-3.1 - EXHIBIT 3.1 CERTIFICATE OF AMENDMENT - PROLUNG INC | f8k040517_ex3z1.htm |
______________________________________________________________________________________________________
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_______________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): April 3, 2017
ProLung, Inc. |
(Exact Name of Registrant as Specified in its Charter) |
Delaware | 000-54600 | 20-1922768 |
(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (IRS Employer Identification No.) |
757 East South Temple |
|
Suite 150 |
|
Salt Lake City, Utah | 84102 |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant's Telephone Number, Including Area Code: |
(801) 204-9623 |
Fresh Medical Laboratories, Inc. |
(Former name, former address, and formal fiscal year, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)
______________________________________________________________________________________________________
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
On April 3, 2017, the Registrant filed a certificate of amendment to its certificate of incorporation with the Secretary of State of the State of Delaware in order to change its name from “Fresh Medical Laboratories, Inc.” to “ProLung, Inc.” The purpose of the name change is to align the name of the Registrant with the brand name of its existing products.
Item 9.01 Exhibits
(d) Exhibits
| Exhibit Number |
Description |
| 3.1 | Certificate of Amendment to Certificate of Incorporation |
SIGNATURES
Pursuant to the requirements of the Securities Exchange of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ProLung, Inc.
Dated: April 6, 2017
By: /s/ Steven C. Eror
Steven C. Eror, Chief Executive Officer